The dose of the first- or second-generation β blocker that the patient is receiving is an important consideration for the switching regimen chosen. The major factors to be kept in mind when ...

Additionally, Raymond James has raised its rating on Block (SQ) to Outperform with a price target of $115, expressing confidence in the company's growth prospects for 2025. To watch more expert ...

Janet Berry-Johnson, CPA, is a freelance writer with a background in accounting and income tax planning and preparation for individuals and small businesses. Her work has appeared in Business ...

Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.

Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is a commonly encountered yet loosely defined clinical entity. ACOS accounts for approximately 15–25% of the ...